Berk P D
Hepatology. 1993 Jul;18(1):206-15.
Health care costs are climbing throughout the western world. Aging populations and the costs of advanced technology are the principal forces behind much of this global increase. No country has yet succeeded in containing these growing costs other than by some form of rationing. A variety of experimental strategies, including managed competition, are being considered or tested, but none is clearly effective. American health care expenditures differ, not in that they are rising, but in their enormously high starting point. Among other things, our higher costs reflect administrative costs of more than 20%, double those of Canada and nearly triple the European average; a malpractice system that, whatever its possible advantages, costs more than 10 times as much as it pays out to the injured; the enormous medical costs of poverty; maldistribution of physician specialties and incomes; and reimbursement systems that eliminate consumer input and oversight. Restructuring the system of health care financing to bring administrative costs in line with those of other nations could save at least $70 billion annually; another $25 billion or more could be saved by replacing the malpractice system with more cost-effective alternatives. These savings could defray the costs of insuring all those not now covered, without increasing either costs to the middle class, through taxation of benefits, or total health care expenditures. With all Americans covered, the necessary restructuring of the system of health care delivery could be conducted without the current pressure for immediate drastic reform, which carries with it the risk of serious error. In dealing with the sick, physicians are taught to apply two maxims: "primum non nocere" or "first of all, do no harm!"; and the rule of therapeutic restraint. The latter states that a severe chronic illness may respond better, and with fewer complications, to gradual corrective measures than to highly aggressive therapy. Both rules could well be applied to curing the American health care system.
在整个西方世界,医疗保健费用都在攀升。人口老龄化和先进技术成本是全球费用增长的主要推动因素。除了某种形式的配给制,没有哪个国家成功控制住了这些不断增长的费用。包括管理竞争在内的各种试验性策略正在被考虑或测试,但没有一种明显有效。美国的医疗保健支出不同之处不在于它们在上涨,而在于其起点极高。除此之外,我们较高的成本反映出行政成本超过20%,是加拿大的两倍,几乎是欧洲平均水平的三倍;一个医疗事故制度,无论其可能有什么优点,其成本是赔付给伤者金额的10倍多;贫困带来的巨大医疗成本;医生专业和收入分配不均;以及消除消费者投入和监督的报销制度。重组医疗保健融资体系以使行政成本与其他国家接轨,每年至少可节省700亿美元;用更具成本效益的替代方案取代医疗事故制度,还可再节省250亿美元或更多。这些节省下来的资金可以支付为目前未参保者提供保险的费用,而不会通过对福利征税增加中产阶级的成本,也不会增加医疗保健总支出。在所有人都参保的情况下,可以在没有当前立即进行大刀阔斧改革的压力的情况下进行必要的医疗保健提供体系重组,而这种压力会带来严重错误的风险。在治疗病人时,医生被教导要遵循两条准则:“首要的是不伤害”;以及治疗克制原则。后者指出,对于严重的慢性病,渐进的纠正措施可能比积极的治疗反应更好,并发症也更少。这两条准则都很适用于治愈美国的医疗保健系统。